Company news
Biodesix, Inc. news in 2026
Biodesix, Inc.'s news releases, calls and decks from 2026, newest first.
Biodesix to Participate in Upcoming Investor Conferences
November 4, 2026
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
October 22, 2026
American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification
October 19, 2026
Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
October 19, 2026
Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
October 13, 2026
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
September 14, 2026
Biodesix Announces Second Quarter 2026 Results and Highlights
August 5, 2026
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
August 4, 2026
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
May 11, 2026
Biodesix Announces First Quarter 2026 Results and Highlights
May 4, 2026
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
April 20, 2026
Biodesix Recognized as a Top Workplace for Third Consecutive Year
April 9, 2026
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
April 5, 2026
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
March 19, 2026
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
February 25, 2026
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
January 12, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (August 2026)
Investor deck · 34 slides · August 2026